Under construction – not a live service
Sign in

What researchers published on Myelodysplastic syndromes

906 papers, newest first.

Showing 20 of 906

  • Not labelled yetMicroRNA dysregulation in mesenchymal stromal cells in myelodysplastic syndromes and its modulation by azacitidine and bortezomib.Leukemia & lymphoma
  • ReviewSGLT2 Inhibitors and Hemoglobin Improvement in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: Mechanistic Rationale and Emerging Clinical Evidence.Anemia
  • Not labelled yetMesenchymal stromal cells drive immune escape in MDS and sAML through metabolic rewiring of NK cells.Leukemia
  • Not labelled yetIntegrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes.Blood neoplasia
  • PreprintPersistent Malignant Stem Cells Drive Relapse After Transplantation in the Myelodysplastic Neoplasms.bioRxiv : the preprint server for biology
  • Not labelled yetLuspatercept in Myelodysplastic Syndromes With Ring Sideroblasts: Long Term Outcome and Impact on Non-Erythroid Blood Counts.Hematological oncology
  • Not labelled yetImpact of Venetoclax Bridging on Haematopoietic Stem Cell Transplantation Outcomes in Advanced Myelodysplastic Neoplasms.Transplantation and cellular therapy
  • Not labelled yetNUDT21 knockdown modulates alternative polyadenylation and promotes leukemic transformation in myelodysplastic syndromes.Neoplasma
  • Not labelled yetMolecular and clinical profiling of SF3B1, U2AF1, and SRSF2 mutations in Iranian patients with myelodysplastic neoplasms.Molecular biology reports
  • Not labelled yetFrontline isocitrate dehydrogenase inhibitor therapy in isocitrate dehydrogenase-mutated myelodysplastic neoplasms.Haematologica
  • Not labelled yetPrevalence and prognostic implications of systemic autoinflammatory and autoimmune diseases in myelodysplastic neoplasms: a retrospective Belgian cohort study.Clinical and experimental medicine
  • Not labelled yetGATA2 Deficiency Presenting With a WHIM-Like Phenotype and Subsequent Development of Monosomy 7-Associated Myelodysplastic Syndrome in an Adolescent Female: A Case Report.Clinical case reports
  • Review[Hematological features and advancement in the diagnosis of VEXAS syndrome].Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
  • Not labelled yetWillingness to Pay for Temporary Transfusion Independence in Lower-Risk Myelodysplastic Syndromes: Evidence from a Cross-Sectional Study in China.Patient preference and adherence
  • Not labelled yetComplement deposition in the bone marrow of patients with myelodysplastic neoplasms.Signal transduction and targeted therapy
  • Not labelled yetCan we better evaluate responses in higher-risk myelodysplastic syndromes?Haematologica
  • Not labelled yetInfectious burden and cellular immune impairment in higher-risk myelodysplastic syndromes with biallelic TP53 alterations.Frontiers in cellular and infection microbiology
  • Review[Advances in the management of myelodysplastic neoplasms].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Case reportPearls & Oy-sters: Beyond the Bone Marrow-VEXAS Syndrome Presenting as Subacute Encephalomyelitis.Neurology
  • Not labelled yetA Novel Insight Into Luspatercept: Therapeutic Implications in Myelodysplastic Syndrome Patients With Elevated Pulmonary Artery Systolic Pressure.Pulmonary circulation